Variations in rodent models of type 1 diabetes: Islet morphology

Journal of Diabetes Research

Volumn 2013, Issue , 2013, Pages

  Novikova, Lesya ^a   Smirnova, Irina V ^a   Rawal, Sonia ^a   Dotson, Abby L ^b   Benedict, Stephen H ^b   Stehno Bittel, Lisa ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; GLUCOSE BLOOD LEVEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOBREEDING RAT; CELL COMPOSITION; CELL LEVEL; CELL LOSS; CELL SHAPE; CELL SIZE; CONTROLLED STUDY; DARK AGOUTI RAT; IMMUNOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMMUNOLOGY; MALE; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPERGLYCEMIA; ISLETS OF LANGERHANS; MALE; MICE; RATS;

EID: 84878737521     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2013/965832     Document Type: Article

References (26)

1. Thayer T. C., Wilson S. B., Mathews C. E., Use of nonobese diabetic mice to understand human type 1 diabetes. Endocrinology and Metabolism Clinics of North America 2010 39 3 541 561 2-s2.0-77955756080 10.1016/j.ecl.2010.05.001
2. Hall S., Cooke A., Autoimmunity and inflammation: murine models and translational studies. Mammalian Genome 2011 22 7-8 377 389
3. Anderson M. S., Bluestone J. A., The NOD mouse: a model of immune dysregulation. Annual Review of Immunology 2005 23 447 485 2-s2.0-17644361955 10.1146/annurev.immunol.23.021704.115643 (Pubitemid 40563177)
4. Driver J. P., Serreze D. V., Chen Y. G., Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease. Seminars in Immunopathology 2011 33 1 67 87 2-s2.0-79251621206 10.1007/s00281-010-0204-1
5. Yeung W. C., Rawlinson W. D., Craig M. E., Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. The British Medical Journal 2011 342 article d35 2-s2.0-79952266234 10.1136/bmj.d35
6. Laron Z., Interplay between heredity and environment in the recent explosion of type 1 childhood diabetes mellitus. The American Journal of Medical Genetics 2002 115 1 4 7 2-s2.0-0036072236 10.1002/ajmg.10338 (Pubitemid 34650718)
7. Bortell R., Pino S. C., Greiner D. L., Zipris D., Rossini A. A., Closing the circle between the bedside and the bench: toll-like receptors in models of virally induced diabetes. Annals of the New York Academy of Sciences 2008 1150 112 122 2-s2.0-57749205591 10.1196/annals.1447.025
8. Greiner D. L., Mordes J. P., Handler E. S., Depletion of RT6.1+ T lymphocytes induces diabetes in resistant biobreeding/Worcester (BB/W) rats. Journal of Experimental Medicine 1987 166 2 461 475 2-s2.0-0023267515 (Pubitemid 17134025)
9. Bortell R., Yang C., The BB rat as a model of human type 1 diabetes. Methods in Molecular Biology 2012 933 31 44
10. Szkudelski T., The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiological Research 2001 50 6 537 546 2-s2.0-0035691617 (Pubitemid 34087272)
11. Lee J. H., Yanga S. H., Oha J. M., Lee M. G., Pharmacokinetics of drugs in rats with diabetes mellitus induced by alloxan or streptozocin: comparison with those in patients with type I diabetes mellitus. Journal of Pharmacy and Pharmacology 2010 62 1 1 23 2-s2.0-77949527303 10.1211/jpp/62.01.0001
12. Grant C., Duclos S. K., Moran-Paul C. M., Yahalom B., Tirabassi R. S., Arreaza-Rubin G., Spain L. M., Guberski D. L., Development of standardized insulin treatment protocols for spontaneous rodent models of type 1 diabetes. Comparative Medicine 2012 62 5 381 390
13. Loganathan R., Novikova L., Boulatnikov I. G., Smirnova I. V., Exercise-induced cardiac performance in autoimmune (Type 1) diabetes is associated with a decrease in myocardial diacylglycerol. Journal of Applied Physiology 2012 113 5 817 826
14. Farmer K., Williams S. J., Novikova L., Ramachandran K., Rawal S., Blagg B. S., Dobrowsky R., Stehno-Bittel L., KU-32, a novel drug for diabetic neuropathy, is safe for human islets and improves in vitro insulin secretion and viability. Experimental Diabetes Research 2012 2012 671673
15. Huang H., Farmer K., Windscheffel J., Yost K., Power M., Wright D. E., Stehno-Bittel L., Exercise increases insulin content and basal secretion in pancreatic islets in type 1 diabetic mice. Experimental Diabetes Research. 2011 2011 481427
16. Atkinson M. A., Leiter E. H., The NOD mouse model of type 1 diabetes: as good as it gets? Nature Medicine 1999 5 6 601 604 2-s2.0-0033001488 10.1038/9442 (Pubitemid 29289413)
17. Couzin-Frankel J., Clinical studies. Trying to reset the clock on type 1 diabetes. Science 2011 333 6044 819 821
18. Brehm M., Powers A. C., Shultz L. D., Griener D. L., Advancing animal models of human type 1 diabetes by engraftment of functional human tissues in immunodeficient mice. Cold Spring Harbor Perspectives in Medicine 2012 2012 2 007757
19. Eizirik D. L., Pipeleers D. G., Ling Z., Welsh N., Hellerstrom C., Andersson A., Major species differences between humans and rodents in the susceptibility to pancreatic β -cell injury. Proceedings of the National Academy of Sciences of the United States of America 1994 91 20 9253 9256 2-s2.0-0028049833 (Pubitemid 24297892)
20. Pipeleers D., van de Winkel M., Dyrberg T., Lernmark A., Spontaneously diabetic BB rats have age-dependent islet β -cell-specific surface antibodies at clinical onset. Diabetes 1987 36 10 1111 1115 2-s2.0-0023629627 (Pubitemid 17163415)
21. In't Veld P. A., Pipeleers D. G., In situ analysis of pancreatic islets in rats developing diabetes. Appearance of nonendocrine cells with surface MHC class II antigens and cytoplasmic insulin immunoreactivity. Journal of Clinical Investigation 1988 82 3 1123 1128 2-s2.0-0023784449
22. Orci L., Baetens D., Rufener C., Amherdt M., Ravazzola M., Studer P., Malaisse-Lagae F., Unger R. H., Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes. Proceedings of the National Academy of Sciences of the United States of America 1976 73 4 1338 1342
23. Wang L., Lovejoy N. F., Faustman D. L., Persistence of prolonged C-peptide production in type 1 diabetes as measured with an ultrasensitive C-peptide assay. Diabetes Care 2012 35 3 465 470
24. Trudeau J., Dutz J. P., Arany E., Hill D. J., Fieldus W. E., Finegood D. T., Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes? Diabetes 2000 49 1 1 7 (Pubitemid 30022916)
25. Bouma G., Coppens J. M. C., Mourits S., Nikolic T., Sozzani S., Drexhage H. A., Versnel M. A., Evidence for an enhanced adhesion of DC to fibronectin and a role of CCL19 and CCL21 in the accumulation of DC around the pre-diabetic islets in NOD mice. The European Journal of Immunology 2005 35 8 2386 2396 2-s2.0-23844531972 10.1002/eji.200526251 (Pubitemid 41179759)
26. Delovitch T., Singh B., The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 1997 7 6 291 297